Ascendis Pharma - 48 Year Dividend History | ASND

Historical dividend payout and yield for Ascendis Pharma (ASND) since 1971. The current TTM dividend payout for Ascendis Pharma (ASND) as of July 17, 2019 is $0.00. The current dividend yield for Ascendis Pharma as of July 17, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $4.867B $0.013B
Ascendis Pharma A/S is a biopharmaceutical company. The company's product pipeline consist of TransCon Human Growth Hormone, TransCon Treprostinil, TransCon Insulin, TransCon Peptide and TransCon Ranibizumab, which are in different clinical stage, for the treatments of hormone deficiency, endocrinology, central nervous system disorders, infectious diseases and diabetes. Its technology includes TransCon which develop prodrug therapies. Ascendis Pharma A/S is based in Denmark.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $108.245B 12.24
Gilead Sciences (GILD) United States $85.342B 10.36
CSL (CSLLY) Australia $35.409B 0.00
Bio-Techne Corp (TECH) United States $7.964B 54.34